iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Large Volume Increase – Should You Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw strong trading volume on Thursday . Approximately 289,496 shares traded hands during mid-day trading, an increase of 189% from the previous session’s volume of 100,329 shares.The stock last traded at $95.85 and had previously closed at $95.08.

iShares U.S. Pharmaceuticals ETF Price Performance

The stock has a market cap of $1.04 billion, a price-to-earnings ratio of 17.75 and a beta of 0.50. The firm has a fifty day moving average of $90.05 and a 200 day moving average of $88.02.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Hudock Inc. raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 3.9% in the 4th quarter. Hudock Inc. now owns 3,034 shares of the company’s stock valued at $257,000 after acquiring an additional 114 shares during the period. Sunbelt Securities Inc. grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 14.3% in the first quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock valued at $83,000 after buying an additional 120 shares in the last quarter. O Shaughnessy Asset Management LLC grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 35.0% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after buying an additional 120 shares in the last quarter. National Bank of Canada FI raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after buying an additional 175 shares during the period. Finally, Root Financial Partners LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 36.5% in the 1st quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after buying an additional 186 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.